Latest Conference Articles

October 17th 2018, 9:46pm

State of the Science Summit on GI Malignancies

Heinz-Josef Lenz, MD, discusses the intersection between the molecular makeup of colorectal cancer and the development of novel therapies in the treatment paradigm.

October 17th 2018, 1:36am

State of the Science Summit on GI Malignancies

Anthony El-Khoueiry, MD, associate professor of clinical medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, discusses recent combination data in hepatocellular carcinoma.

October 17th 2018, 12:34am

State of the Science Summit on GI Malignancies

Syma Iqbal, MD, associate professor of clinical medicine, Keck School of Medicine, University of Southern California, discusses treatment options for patients with neuroendocrine tumors (NETs).

October 16th 2018, 10:00am

State of the Science Summit on GI Malignancies

Heinz-Josef Lenz, MD, associate director for Adult Oncology and co-leader of the Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, discusses the FDA breakthrough designation status of encorafenib (Braftovi), binimetinib (Mektovi), and cetuximab (Erbitux) for the treatment of patients with BRAF V600E-mutant metastatic colorectal cancer (CRC).

October 16th 2018, 12:24am

State of the Science Summit on GI Malignancies

Heinz-Josef Lenz, MD, associate director for Adult Oncology and co-leader of the Gastrointestinal Cancers Program, USC Norris Comprehensive Cancer Center, discusses the changing landscape of metastatic colorectal cancer (mCRC).

October 14th 2018, 11:32pm

Lynn Sage Breast Cancer Symposium

Massimo Cristofanilli, MD, discusses a session at the 20th Annual Lynn Sage Breast Cancer Symposium on the roles of a multidisciplinary team.

October 14th 2018, 11:30pm

Lynn Sage Breast Cancer Symposium

George Sledge, Jr., MD, discusses the benefit to the cost of genomic sequencing decreasing overtime.

October 14th 2018, 9:34pm

Lynn Sage Breast Cancer Symposium

As the cost of sequencing continues to fall, genomic testing will likely become widespread in all types of metastatic cancer, including breast cancer.

October 14th 2018, 9:08pm

Lynn Sage Breast Cancer Symposium

William J. Gradishar, MD, discusses how far the breast cancer field has advanced over the last 20 years and the data he is anticipating to read out in the future.

October 14th 2018, 9:00pm

Lynn Sage Breast Cancer Symposium

Multiple gene signature assays have been developed that supply prognostic information for decisions on adjuvant chemotherapy and whether therapy should be of extended duration.

October 14th 2018, 1:00am

Lynn Sage Breast Cancer Symposium

Determining the optimal adjuvant therapy in young women with breast cancer remains challenging, but some clarity is beginning to emerge.

October 13th 2018, 7:35pm

Lynn Sage Breast Cancer Symposium

Kathryn Ruddy, MD, discusses how genetic testing could impact treatment of patients with breast cancer.

October 13th 2018, 5:17pm

Lynn Sage Breast Cancer Symposium

Andrea V. Barrio, MD, discusses the challenges with phyllodes tumors of the breast and how to manage this disease moving forward.

October 13th 2018, 5:13pm

Lynn Sage Breast Cancer Symposium

Elizabeth Mittendorf, MD, PhD, discusses the rationale for updating the AJCC staging system in patients with breast cancer. This system was originally developed in the 1970s but is still used today.

October 13th 2018, 4:27pm

Lynn Sage Breast Cancer Symposium

All triple-negative breast cancers are not created equal, and clinicians should consider their inherent heterogeneity during diagnosis and treatment planning.

October 13th 2018, 12:25am

Lynn Sage Breast Cancer Symposium

Monica Morrow, MD, addresses how she treats patients with breast cancer who have locoregional recurrence and how therapeutic approaches have evolved over recent years.

October 12th 2018, 9:21pm

Lynn Sage Breast Cancer Symposium

Sara McLaughlin, MD, professor of Surgery, Mayo Clinic, discusses the frequency that lymphedema appears in patients with breast cancer and addresses the complications in identifying this after her presentation at the Lynn Sage Breast Cancer Symposium.

October 12th 2018, 8:32pm

State of the Science Summit on GI Malignancies

Afsaneh Barzi, MD, assistant professor of clinical medicine, USC Norris Comprehensive Cancer Center, discusses surgical advances in the treatment of patients with pancreatic cancer.

October 12th 2018, 7:38pm

Lynn Sage Breast Cancer Symposium

Just as immunotherapies are transforming clinical practice for oncologists, these new therapies are also changing the practice of pathology and offering new ways for oncologists and pathologists to collaborate and improve patient care.

October 12th 2018, 6:15pm

Lynn Sage Breast Cancer Symposium

Luis Z. Blanco Jr., MD, assistant professor of Pathology, Northwestern University, discusses the role a pathologist plays in the treatment of a patient with breast cancer during a presentation at the Lynn Sage Breast Cancer Symposium.